Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 20 June 1986:
Vol. 232. no. 4757, pp. 1548 - 1553
DOI: 10.1126/science.3012778
Prev | Table of Contents | Next

Articles

Science, Vol 232, Issue 4757, 1548-1553
Copyright © 1986 by American Association for the Advancement of Science

articles

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS

BH Hahn, GM Shaw, ME Taylor, RR Redfield, PD Markham, SZ Salahuddin, F Wong-Staal, RC Gallo, ES Parks, and WP Parks

In a study of genetic variation in the AIDS virus, HTLV-III/LAV, sequential virus isolates from persistently infected individuals were examined by Southern blot genomic analysis, molecular cloning, and nucleotide sequencing. Four to six virus isolates were obtained from each of three individuals over a 1-year or 2-year period. Changes were detected throughout the viral genomes and consisted of isolated and clustered nucleotide point mutations as well as short deletions or insertions. Results from genomic restriction mapping and nucleotide sequence comparisons indicated that viruses isolated sequentially had evolved in parallel from a common progenitor virus. The rate of evolution of HTLV-III/LAV was estimated to be at least 10(-3) nucleotide substitutions per site per year for the env gene and 10(-4) for the gag gene, values a millionfold greater than for most DNA genomes. Despite this relatively rapid rate of sequence divergence, virus isolates from any one patient were all much more related to each other than to viruses from other individuals. In view of the substantial heterogeneity among most independent HTLV-III/LAV isolates, the repeated isolation from a given individual of only highly related viruses raises the possibility that some type of interference mechanism may prevent simultaneous infection by more than one major genotypic form of the virus.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Human Immunodeficiency Virus Type 1 V1-to-V5 Envelope Variants from the Chronic Phase of Infection Use CCR5 and Fuse More Efficiently than Those from Early after Infection.
B. Etemad, A. Fellows, B. Kwambana, A. Kamat, Y. Feng, S. Lee, and M. Sagar (2009)
J. Virol. 83, 9694-9708
   Abstract »    Full Text »    PDF »
From the Cover: The emergence of HIV/AIDS in the Americas and beyond.
M. T. P. Gilbert, A. Rambaut, G. Wlasiuk, T. J. Spira, A. E. Pitchenik, and M. Worobey (2007)
PNAS 104, 18566-18570
   Abstract »    Full Text »    PDF »
A Cophylogenetic Perspective of RNA-Virus Evolution.
A. P. Jackson and M. A. Charleston (2004)
Mol. Biol. Evol. 21, 45-57
   Abstract »    Full Text »    PDF »
Substitutions of Phe61 Located in the Vicinity of Template 5'-Overhang Influence Polymerase Fidelity and Nucleoside Analog Sensitivity of HIV-1 Reverse Transcriptase.
T. S. Fisher and V. R. Prasad (2002)
J. Biol. Chem. 277, 22345-22352
   Abstract »    Full Text »    PDF »
Antiviral Actions of Interferons.
C. E. Samuel (2001)
Clin. Microbiol. Rev. 14, 778-809
   Abstract »    Full Text »    PDF »
Sequences of Citrus Tristeza Virus Separated in Time and Space Are Essentially Identical.
M. R. Albiach-Martí, M. Mawassi, S. Gowda, T. Satyanarayana, M. E. Hilf, S. Shanker, E. C. Almira, M. C. Vives, C. López, J. Guerri, et al. (2000)
J. Virol. 74, 6856-6865
   Abstract »    Full Text »
Neutralization Profiles of Sera from Human Immunodeficiency Virus (HIV)-Infected Individuals: Relationship to HIV Viral Load and CD4 Cell Count.
M. Nokta, P. Turk, K. Loesch, and R. B. Pollard (2000)
Clin. Vaccine Immunol. 7, 412-416
   Abstract »    Full Text »    PDF »
Genetic Stability of Foamy Viruses: Long-Term Study in an African Green Monkey Population.
M. Schweizer, H. Schleer, M. Pietrek, J. Liegibel, V. Falcone, and D. Neumann-Haefelin (1999)
J. Virol. 73, 9256-9265
   Abstract »    Full Text »    PDF »
Evolution of Envelope Sequences of Human Immunodeficiency Virus Type 1 in Cellular Reservoirs in the Setting of Potent Antiviral Therapy.
H. F. Gunthard, S. D. W. Frost, A. J. Leigh-Brown, C. C. Ignacio, K. Kee, A. S. Perelson, C. A. Spina, D. V. Havlir, M. Hezareh, D. J. Looney, et al. (1999)
J. Virol. 73, 9404-9412
   Abstract »    Full Text »    PDF »
Methods for Subtyping and Molecular Comparison of Human Viral Genomes.
M. Arens (1999)
Clin. Microbiol. Rev. 12, 612-626
   Abstract »    Full Text »    PDF »
Th1 T Cell Responses to HIV-1 Gag Protein Delivered by a Listeria monocytogenes Vaccine Are Similar to Those Induced by Endogenous Listerial Antigens.
M. Mata and Y. Paterson (1999)
J. Immunol. 163, 1449-1456
   Abstract »    Full Text »    PDF »
Potential Contributions of Viral Envelope and Host Genetic Factors in a Human Immunodeficiency Virus Type 1-Infected Long-Term Survivor.
K. Grovit-Ferbas, J. Ferbas, V. Gudeman, S. Sadeghi, M. B. Goetz, J. V. Giorgi, I. S. Y. Chen, and W. A. O'Brien (1998)
J. Virol. 72, 8650-8658
   Abstract »    Full Text »    PDF »
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline.
R. B. Markham, W.-C. Wang, A. E. Weisstein, Z. Wang, A. Munoz, A. Templeton, J. Margolick, D. Vlahov, T. Quinn, H. Farzadegan, et al. (1998)
PNAS 95, 12568-12573
   Abstract »    Full Text »    PDF »
Substitutions in a Major Histocompatibility Complex Class II-Restricted Human Immunodeficiency Virus Type 1 gp120 Epitope Can Affect CD4+ T-Helper-Cell Function.
C. Lekutis and N. L. Letvin (1998)
J. Virol. 72, 5840-5844
   Abstract »    Full Text »    PDF »
Increased Misincorporation Fidelity Observed for Nucleoside Analog Resistance Mutations M184V and E89G in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Does Not Correlate with the Overall Error Rate Measured In Vitro.
W. C. Drosopoulos and V. R. Prasad (1998)
J. Virol. 72, 4224-4230
   Abstract »    Full Text »    PDF »
Tracking Members of the Simian Immunodeficiency Virus deltaB670 Quasispecies Population In Vivo at Single-Cell Resolution.
T. A. Reinhart, M. J. Rogan, A. M. Amedee, M. Murphey-Corb, D. M. Rausch, L. E. Eiden, and A. T. Haase (1998)
J. Virol. 72, 113-120
   Abstract »    Full Text »    PDF »
Misincorporation by HIV-1 Reverse Transcriptase Promotes Recombination via Strand Transfer Synthesis.
C. Palaniappan, M. Wisniewski, W. Wu, P. J. Fay, and R. A. Bambara (1996)
J. Biol. Chem. 271, 22331-22338
   Abstract »    Full Text »    PDF »
The Emerging Genetic Diversity of HIV: The Importance of Global Surveillance for Diagnostics, Research, and Prevention.
D. J. Hu, T. J. Dondero, M. A. Rayfield, J. R. George, G. Schochetman, H. W. Jaffe, C.-C. Luo, M. L. Kalish, B. G. Weniger, C.-P. Pau, et al. (1996)
JAMA 275, 210-216
   Abstract »    PDF »
Application and accuracy of molecular phylogenies.
D. Hillis, J. Huelsenbeck, and C. Cunningham (1994)
Science 264, 671-677
   Abstract »    PDF »
Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice.
Corboy JR, J. Buzy, M. Zink, and J. Clements (1992)
Science 258, 1804-1808
   Abstract »    PDF »
Molecular Epidemiology of HIV Transmission in a Dental Practice.
C.-Y. Ou, C. A. Ciesielski, G. Myers, C. I. Bandea, C.-C. Luo, B. T. M. Korber, J. I. Mullins, G. Schochetman, R. L. Berkelman, A. N. Economou, et al. (1992)
Science 256, 1165-1171
   Abstract »    PDF »
LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur.
S Wain-Hobson, J. Vartanian, M Henry, N Chenciner, R Cheynier, S Delassus, L. Martins, M Sala, M. Nugeyre, D Guetard, et al. (1991)
Science 252, 961-965
   Abstract »    PDF »
Biological Agents in Infectious Diseases.
S. G. Louie and G. S. Jaresko (1991)
Journal of Pharmacy Practice 4, 326-341
   Abstract »    PDF »
New Viral Diseases: A Real and Potential Problem Without Boundaries.
E. D. Kilbourne (1990)
JAMA 264, 68-70
   Abstract »    PDF »
Human Immunodeficiency Virus Type 1 (HIV-1) Infection a Median of 18 Months before a Diagnostic Western Blot: Evidence from a Cohort of Homosexual Men.
S. M. Wolinsky, C. R. Rinaldo, S. Kwok, J. J. Sninsky, P. Gupta, D. Imagawa, H. Farzadegan, L. P. Jacobson, K. S. Grovit, M. H. Lee, et al. (1989)
Ann Intern Med 111, 961-972
   Abstract »    PDF »
Prospects for Prevention of and Early Intervention Against HIV.
D. P. Bolognesi (1989)
JAMA 261, 3007-3013
   Abstract »    PDF »
Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection.
A. S. Fauci, R. C. Gallo, S. Koenig, J. Salk, and R. H. Purcell (1989)
Ann Intern Med 110, 373-385
   Abstract »    PDF »
Risk of Developing AIDS in HIV-Infected Cohorts of Hemophilic and Homosexual Men.
J. Jason, K.-J. Lui, M. V. Ragni, N. A. Hessol, and W. W. Darrow (1989)
JAMA 261, 725-727
   Abstract »    PDF »
Fidelity of HIV-1 reverse transcriptase.
B. Preston, B. Poiesz, and L. Loeb (1988)
Science 242, 1168-1171
   Abstract »    PDF »
The accuracy of reverse transcriptase from HIV-1.
J. Roberts, K Bebenek, and T. Kunkel (1988)
Science 242, 1171-1173
   Abstract »    PDF »
Development and testing of AIDS vaccines.
W. Koff and D. Hoth (1988)
Science 241, 426-432
   Abstract »    PDF »
Type-restricted neutralization of molecular clones of human immunodeficiency virus.
D. Looney, A. Fisher, S. Putney, Rusche JR, R. Redfield, D. Burke, R. Gallo, and F Wong-Staal (1988)
Science 241, 357-359
   Abstract »    PDF »
The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.
R. Price, B Brew, J Sidtis, M Rosenblum, A. Scheck, and P Cleary (1988)
Science 239, 586-592
   Abstract »    PDF »
DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.
C. Ou, S Kwok, S. Mitchell, D. Mack, J. Sninsky, J. Krebs, P Feorino, D Warfield, and G Schochetman (1988)
Science 239, 295-297
   Abstract »    PDF »
Pediatric Acquired Immunodeficiency Syndrome: Neurologic Syndromes.
A. L. Belman, G. Diamond, D. Dickson, D. Horoupian, J. Llena, G. Lantos, and A. Rubinstein (1988)
Arch Pediatr Adolesc Med 142, 29-35
   Abstract »    PDF »
Neurologic Manifestations of Infection with Human Immunodeficiency Virus: Clinical Features and Pathogenesis.
D. H. GABUZDA and M. S. HIRSCH (1987)
Ann Intern Med 107, 383-391
   Abstract »    PDF »
Functional interaction and partial homology between human immunodeficiency virus and neuroleukin.
M. Lee, D. Ho, and M. Gurney (1987)
Science 237, 1047-1051
   Abstract »    PDF »
Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.
Y Koyanagi, S Miles, R. Mitsuyasu, J. Merrill, H. Vinters, and I. Chen (1987)
Science 236, 819-822
   Abstract »    PDF »
Characterization and clinical association of antibody inhibitory to HIV reverse transcriptase activity.
J Laurence, A Saunders, and J Kulkosky (1987)
Science 235, 1501-1504
   Abstract »    PDF »
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.
S. Putney, T. Matthews, W. Robey, D. Lynn, M Robert-Guroff, W. Mueller, A. Langlois, J Ghrayeb, S. Petteway Jr, K. Weinhold, et al. (1986)
Science 234, 1392-1395
   Abstract »    PDF »
The Epidemiology of the Human Immunodeficiency Virus Infection.
N. Mueller (1986)
J. Law Med. Ethics 14, 250-258
   PDF »
Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons.
M. Gurney, S. Heinrich, M. Lee, and H. Yin (1986)
Science 234, 566-574
   Abstract »    PDF »
Neuroleukin: a lymphokine product of lectin-stimulated T cells.
M. Gurney, B. Apatoff, G. Spear, M. Baumel, J. Antel, M. Bania, and A. Reder (1986)
Science 234, 574-581
   Abstract »    PDF »
Differential Influence of Nucleoside Analog-resistance Mutations K65R and L74V on the Overall Mutation Rate and Error Specificity of Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
F. S. Shah, K. A. Curr, M. E. Hamburgh, M. Parniak, H. Mitsuya, J. G. Arnez, and V. R. Prasad (2000)
J. Biol. Chem. 275, 27037-27044
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)